Stokes Capital Advisors LLC Has $2 Million Stake in Colgate-Palmolive (NYSE:CL)

Stokes Capital Advisors LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 20.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,932 shares of the company’s stock after buying an additional 4,402 shares during the quarter. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $2,001,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Evolution Wealth Advisors LLC lifted its stake in Colgate-Palmolive by 158.4% in the third quarter. Evolution Wealth Advisors LLC now owns 323 shares of the company’s stock valued at $25,000 after buying an additional 198 shares during the period. Balentine LLC acquired a new position in Colgate-Palmolive in the first quarter valued at about $36,000. Keebeck Wealth Management LLC acquired a new position in Colgate-Palmolive in the second quarter valued at about $41,000. Capital Advisory Group Advisory Services LLC acquired a new position in Colgate-Palmolive in the first quarter valued at about $45,000. Finally, Okabena Investment Services Inc. acquired a new position in Colgate-Palmolive in the second quarter valued at about $51,000. 76.74% of the stock is currently owned by hedge funds and other institutional investors.

In other news, VP Philip G. Shotts sold 401 shares of the firm’s stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of $77.29, for a total value of $30,993.29. Following the completion of the sale, the vice president now directly owns 41,263 shares of the company’s stock, valued at $3,189,217.27. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP John J. Huston sold 84,905 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $77.18, for a total value of $6,552,967.90. Following the completion of the sale, the senior vice president now directly owns 82,988 shares of the company’s stock, valued at $6,405,013.84. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 256,994 shares of company stock valued at $19,678,851. Corporate insiders own 0.78% of the company’s stock.

A number of equities research analysts have recently commented on CL shares. Royal Bank of Canada reaffirmed a “buy” rating and set a $88.00 price target on shares of Colgate-Palmolive in a research report on Thursday, July 30th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, July 31st. Morgan Stanley raised their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Colgate-Palmolive from $75.00 to $78.00 and gave the stock a “hold” rating in a research report on Monday, August 3rd. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $75.27.

CL stock opened at $80.31 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.92 and a debt-to-equity ratio of 9.40. The business has a 50 day moving average price of $77.55 and a two-hundred day moving average price of $73.84. The company has a market cap of $68.86 billion, a price-to-earnings ratio of 26.86, a P/E/G ratio of 4.63 and a beta of 0.59. Colgate-Palmolive has a twelve month low of $58.49 and a twelve month high of $80.99.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.05. The firm had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. The business’s revenue was up .8% compared to the same quarter last year. During the same period last year, the company earned $0.72 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a $0.44 dividend. The ex-dividend date of this dividend is Thursday, October 22nd. This represents a $1.76 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is 62.19%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Further Reading: How is the S&P 500 index different from the DJIA?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.